Scpharmaceuticals (SCPH) Getting Somewhat Positive Press Coverage, Analysis Finds

Media stories about Scpharmaceuticals (NASDAQ:SCPH) have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Scpharmaceuticals earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.7966851438391 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Several equities analysts have weighed in on SCPH shares. BMO Capital Markets started coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set an “outperform” rating and a $24.00 price objective on the stock. Jefferies Group started coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set a “buy” rating and a $23.00 price objective on the stock. Finally, Leerink Swann started coverage on shares of Scpharmaceuticals in a research report on Tuesday, December 12th. They set an “outperform” rating and a $20.00 price objective on the stock.

Scpharmaceuticals (SCPH) opened at $13.33 on Wednesday. Scpharmaceuticals has a 52-week low of $11.75 and a 52-week high of $18.17. The firm has a market cap of $235.18 and a P/E ratio of -4.61.

In other news, major shareholder 5Am Partners Iv, Llc acquired 654,762 shares of the stock in a transaction on Tuesday, November 21st. The shares were purchased at an average cost of $14.00 per share, for a total transaction of $9,166,668.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.

ILLEGAL ACTIVITY WARNING: “Scpharmaceuticals (SCPH) Getting Somewhat Positive Press Coverage, Analysis Finds” was originally published by Week Herald and is owned by of Week Herald. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://weekherald.com/2017/12/27/scpharmaceuticals-scph-getting-somewhat-positive-press-coverage-analysis-finds-2.html.

About Scpharmaceuticals

scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.

Receive News & Ratings for Scpharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scpharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply